LPL Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
1,500
+900
+150% +$912K ﹤0.01% 3863
2025
Q4
$645K Sell
600
-200
-25% -$191K ﹤0.01% 4488
2025
Q3
$610K Buy
800
+100
+14% +$74.4K ﹤0.01% 4461
2025
Q2
$546K Buy
+700
New +$544K ﹤0.01% 4302
2025
Q1
Sell
-400
Closed -$309K 5450
2024
Q4
$309K Sell
400
-1,300
-76% -$1.08M ﹤0.01% 4505
2024
Q3
$1.51M Buy
1,700
+200
+13% +$180K ﹤0.01% 3002
2024
Q2
$1.36M Buy
1,500
+1,447
+2,730% +$1.16M ﹤0.01% 2960
2024
Q1
$4.12M Sell
53
-1,047
-95% -$745K ﹤0.01% 1937
2023
Q4
$641K Buy
+1,100
New +$642K ﹤0.01% 3452
2019
Q1
Sell
-19,200
Closed -$2.22M 3224
2018
Q4
$2.22M Buy
+19,200
New +$2.14M 0.01% 1020

Other funds holding LLY

LPL Financial's LLY Position: Q1 2026 in Review

LPL Financial increased its Eli Lilly (LLY) stake by 2.1% in Q1 2026, buying an estimated $25.5M and bringing the position to 1,196,696 shares worth $1.1B. The position accounts for 0.29% of the portfolio, ranked #63.

LPL Financial first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.26B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • LPL Financial held 1,196,696 shares of Eli Lilly worth $1.1B as of Q1 2026.
  • LPL Financial bought 25,134 Eli Lilly shares in Q1 2026, an estimated $25.5M.
  • Eli Lilly made up 0.29% of LPL Financial's portfolio in Q1 2026, its #63 holding.
  • LPL Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Eli Lilly position peaked at $1.26B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.